169 related articles for article (PubMed ID: 33627518)
1. New Approaches to Vaccinology Made Possible by Advances in Next Generation Sequencing, Bioinformatics and Protein modeling.
Woolums AR; Swiderski C
Curr Issues Mol Biol; 2021; 42():605-634. PubMed ID: 33627518
[TBL] [Abstract][Full Text] [Related]
2. Immunoinformatics:
Bahrami AA; Payandeh Z; Khalili S; Zakeri A; Bandehpour M
Int Rev Immunol; 2019; 38(6):307-322. PubMed ID: 31478759
[TBL] [Abstract][Full Text] [Related]
3. Reverse Vaccinology for Influenza A Virus: From Genome Sequencing to Vaccine Design.
Di Salvatore V; Russo G; Pappalardo F
Methods Mol Biol; 2023; 2673():401-410. PubMed ID: 37258929
[TBL] [Abstract][Full Text] [Related]
4. Reverse Vaccinology and Its Applications.
Kanampalliwar AM
Methods Mol Biol; 2020; 2131():1-16. PubMed ID: 32162247
[TBL] [Abstract][Full Text] [Related]
5. Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design.
Rappuoli R; Bottomley MJ; D'Oro U; Finco O; De Gregorio E
J Exp Med; 2016 Apr; 213(4):469-81. PubMed ID: 27022144
[TBL] [Abstract][Full Text] [Related]
6. Epitope-based vaccine design: a comprehensive overview of bioinformatics approaches.
Parvizpour S; Pourseif MM; Razmara J; Rafi MA; Omidi Y
Drug Discov Today; 2020 Jun; 25(6):1034-1042. PubMed ID: 32205198
[TBL] [Abstract][Full Text] [Related]
7. Current progress of immunoinformatics approach harnessed for cellular- and antibody-dependent vaccine design.
Kazi A; Chuah C; Majeed ABA; Leow CH; Lim BH; Leow CY
Pathog Glob Health; 2018 May; 112(3):123-131. PubMed ID: 29528265
[TBL] [Abstract][Full Text] [Related]
8. Beyond epitopes: future and application of computational vaccinology.
Söllner J
Hum Vaccin; 2011 Jul; 7(7):795-7. PubMed ID: 21445008
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in veterinary applications of structural vaccinology.
Charleston B; Graham SP
Curr Opin Virol; 2018 Apr; 29():33-38. PubMed ID: 29550741
[TBL] [Abstract][Full Text] [Related]
10. Innovations in structure-based antigen design and immune monitoring for next generation vaccines.
Ward AB; Wilson IA
Curr Opin Immunol; 2020 Aug; 65():50-56. PubMed ID: 32387642
[TBL] [Abstract][Full Text] [Related]
11. Novel vaccine design based on genomics data analysis: A review.
Lu G; Shan S; Zainab B; Ayaz Z; He J; Xie Z; Rashid U; Zhang D; Mehmood Abbasi A
Scand J Immunol; 2021 Mar; 93(3):e12986. PubMed ID: 33043473
[TBL] [Abstract][Full Text] [Related]
12. Structural vaccinology starts to deliver.
Dormitzer PR; Grandi G; Rappuoli R
Nat Rev Microbiol; 2012 Dec; 10(12):807-13. PubMed ID: 23154260
[TBL] [Abstract][Full Text] [Related]
13. Computational vaccinology and the ICoVax 2012 workshop.
He Y; Cao Z; De Groot AS; Brusic V; Schönbach C; Petrovsky N
BMC Bioinformatics; 2013; 14 Suppl 4(Suppl 4):I1. PubMed ID: 23514034
[TBL] [Abstract][Full Text] [Related]
14. The use of databases, data mining and immunoinformatics in vaccinology: where are we?
Hegde NR; Gauthami S; Sampath Kumar HM; Bayry J
Expert Opin Drug Discov; 2018 Feb; 13(2):117-130. PubMed ID: 29226722
[TBL] [Abstract][Full Text] [Related]
15. Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens.
Liljeroos L; Malito E; Ferlenghi I; Bottomley MJ
J Immunol Res; 2015; 2015():156241. PubMed ID: 26526043
[TBL] [Abstract][Full Text] [Related]
16. Computational vaccinology and epitope vaccine design by immunoinformatics.
Khalili S; Jahangiri A; Borna H; Ahmadi Zanoos K; Amani J
Acta Microbiol Immunol Hung; 2014 Sep; 61(3):285-307. PubMed ID: 25261943
[TBL] [Abstract][Full Text] [Related]
17. ReVac: a reverse vaccinology computational pipeline for prioritization of prokaryotic protein vaccine candidates.
D'Mello A; Ahearn CP; Murphy TF; Tettelin H
BMC Genomics; 2019 Dec; 20(1):981. PubMed ID: 31842745
[TBL] [Abstract][Full Text] [Related]
18. Network vaccinology.
Creighton R; Schuch V; Urbanski AH; Giddaluru J; Costa-Martins AG; Nakaya HI
Semin Immunol; 2020 Aug; 50():101420. PubMed ID: 33162295
[TBL] [Abstract][Full Text] [Related]
19. Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii.
Solanki V; Tiwari V
Sci Rep; 2018 Jun; 8(1):9044. PubMed ID: 29899345
[TBL] [Abstract][Full Text] [Related]
20. The Use of Reverse Vaccinology and Molecular Modeling Associated with Cell Proliferation Stimulation Approach to Select Promiscuous Epitopes from Schistosoma mansoni.
Oliveira FM; Coelho IE; Lopes MD; Taranto AG; Junior MC; Santos LL; Villar JA; Fonseca CT; Lopes DD
Appl Biochem Biotechnol; 2016 Jul; 179(6):1023-40. PubMed ID: 26979443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
